Publikācijas » Search Results » 2015

 2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962  1961
Rezultātu skaits lapā  
Konferences
31Vavers E.; Zvejniece L.; Dambrova M. Ligands of sigma-1 receptor: agonists, antagonists, allosteric modulators. P.63 (OP43).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

32Zvejniece L.; Vavers E.; Veinberg G.; Švalbe B.; Domracheva Ilona; Vilšķērsts R.; Dambrova M. Stereoselective pharmacological activity of 4,5-disubstituted piracetam derivatives, positive allosteric modulators of sigma-1 receptor. P.62 (OP42).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

33Kuka J.; Makrecka - Kuka M.; Cīrule H.; Grinberga S.; Dambrova M.; Liepins E. The comparative anti-infarction activity of selective L-carnitine transport and biosynthesis inhibitors. P.54 (OP34).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

34Makrecka - Kuka M.; Voļska K.; Kuka J.; Dambrova M.; Liepins E. Acylcarnitines in mitochondrial bioenergetics. P.46 (OP26).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

35Vilšķērsts R.; Kuka J.; Makrecka - Kuka M.; Volska K.; Makarova E.; Liepins E.; Dambrova M. Attenuation of atherosclerosis development by targeting acylcarnitine pools. P.37 (OP17).. Abstract Book, Drug Discovery conference, Drug Discovery conference ; Riga, Latvia: Riga, Latvia, 2015.      

36Makarova E.; Cīrule H.; Švalbe B.; Volska K.; Vilšķērsts R.; Kuka J.; Liepins E.; Dambrova M. Experimental models for novel anti-diabetic and anti-obesity drug testing. P120. Abstract Book, Drug Discovery conference , Drug Discovery conference ; Riga, Latvia: Riga, Latvia, 2015.      

37Volska K.; Makrecka - Kuka M.; Makarova N.; Svalbe B.; Sevostjanovs E.; Liepins E.; Dambrova M. Decreased acylcarnitine content and increased physical activity improve insulin sensitivity in db/db mice. P160. Abstract Book, Drug Discovery conference, , Drug Discovery conference, ; Riga, Latvia: Riga, Latvia, 2015.      

38Vilšķērsts R.; Kuka J.; Liepins E.; Dambrova M. Experimental models for the development of new cardiovascular drugs. P158.. Abstract Book, Drug Discovery conference, , Drug Discovery conference, ; Riga, Latvia: Riga, Latvia, 2015.      

39Liepins E. Long chain acylcarnitines: new target for treatment of cardiovascular diseases and type 2 diabetes. Drug Discovery conference, P.36 (OP16).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

40Antone U.; Makrecka - Kuka M.; Sevostjanovs E.; Dambrova M.; Liepins E. Plasma and tissue acylcarnitine profile in fed and fasting rats. P.86.. in Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

Rezultātu skaits lapā